Prime Capital Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$154K	Buy	30,346 +11,492	+61%	+$58.2K	﹤0.01%	909
2025 Q1	$99.7K	Buy	18,854 +7,381	+64%	+$39K	﹤0.01%	1007
2024 Q4	$77.6K	Buy	11,473 +1,306	+13%	+$8.83K	﹤0.01%	900
2024 Q3	$67K	Sell	10,167 -11	-0.1%	-$72	﹤0.01%	892
2024 Q2	$76.3K	Buy	+10,178	New	+$76.3K	﹤0.01%	891